PART I Overview We are a biopharmaceutical company using our proprietary Precision Timed Release TM (PTR TM ) drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. With an initial focus on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, we a...
Q2 FY2026 — expected 2026-09-15
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-18 | 2025-12-31 | 0001493152-26-010882 | EDGAR | 113K words |
| 2025-03-27 | 2024-12-31 | 0001641172-25-000970 | EDGAR | — |
| 2024-04-01 | 2023-12-31 | 0001493152-24-012159 | EDGAR | — |
| 2023-03-10 | 2022-12-31 | 0001493152-23-007252 | EDGAR | — |
| 2022-03-28 | 2021-12-31 | 0001493152-22-007903 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-13 | 2025-09-30 | 0001493152-25-022395 | EDGAR | 26K words |
| 2025-08-19 | 2025-06-30 | 0001641172-25-024744 | EDGAR | — |
| 2025-05-08 | 2025-03-31 | 0001641172-25-009289 | EDGAR | — |
| 2024-11-07 | 2024-09-30 | 0001493152-24-043916 | EDGAR | — |
| 2024-08-13 | 2024-06-30 | 0001493152-24-031469 | EDGAR | — |
| 2024-05-08 | 2024-03-31 | 0001493152-24-018159 | EDGAR | — |
| 2023-11-13 | 2023-09-30 | 0001493152-23-040540 | EDGAR | — |
| 2023-08-14 | 2023-06-30 | 0001493152-23-028546 | EDGAR | — |
| 2023-05-10 | 2023-03-31 | 0001493152-23-016183 | EDGAR | — |
| 2022-11-14 | 2022-09-30 | 0001493152-22-031582 | EDGAR | — |
| 2022-08-11 | 2022-06-30 | 0001493152-22-021964 | EDGAR | — |
| 2022-05-12 | 2022-03-31 | 0001493152-22-013104 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-07-23 | 0001493152-26-034402 | EDGAR | — |
| 2026-07-14 | 0001493152-26-033115 | EDGAR | — |
| 2026-04-02 | 0001493152-26-014914 | EDGAR | 1K words |
| 2026-03-24 | 0001493152-26-012417 | EDGAR | — |
| 2026-03-18 | 0001493152-26-010881 | EDGAR | — |
| 2026-02-17 | 0001493152-26-006942 | EDGAR | — |
| 2026-02-06 | 0001493152-26-005561 | EDGAR | — |
| 2026-01-28 | 0001493152-26-004030 | EDGAR | — |
| 2026-01-15 | 0001493152-26-002417 | EDGAR | — |
| 2026-01-02 | 0001493152-26-000142 | EDGAR | — |
151 total filings indexed. 124 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001862150 |
| Ticker | CING |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.cingulate.com |
| Listed | 2021-12-08 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/CING (~200 tokens, structured JSON with cryptographic provenance)